Pyxis Oncology Inc (PYXS)
NASDAQ NMS - GLOBAL MARKET · Biotechnology
$1.69+0.01 (+0.60%)Quote refreshed
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
$202.1M
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
—
Beta
—
Company overview
No company overview is available for Pyxis Oncology Inc yet.
Peers in Biotechnology
All in industry →VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%
Recent press releases
Pyxis Oncology Inc has not issued a press release in this window.
SEC filings
All filings →Pyxis Oncology Inc has not filed an SEC document in this window.
Insider trades
All insider trades →Pyxis Oncology Inc has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
Pfizer Inc$8.1M
7,032,770 sh0.0%
4,121,870 sh● NEW
4,796,479 sh+32.3%
VANGUARD GROUP INC$2.7M
2,335,768 sh+7.9%
1,037,421 sh0.0%
MILLENNIUM MANAGEMENT LLC$854,573
743,107 sh-8.8%
HealthInvest Partners AB$709,831
617,245 sh● NEW
BANK OF AMERICA CORP /DE/$676,029
587,851 sh-4.5%
People at Pyxis Oncology Inc
All people →Quarterly financials
Full financials →Revenue trend
03/25
—
NI -$21.2M
06/25
$2.8M
NI -$18.4M
09/25
—
NI -$22.0M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.35
Prior: $-0.30
Revenue sparkline